The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Vital KSK Holdings 9-Day RSI Related Terms
FRA:4GX vs MCK, CAH, COR: 9-Day RSI Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings 9-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital KSK Holdings (FRA:4GX) has a 9-Day RSI of 59.37 as of Jul. 12, 2026. According to the industry distribution chart, Vital KSK Holdings ranks #100 out of 124 companies in the Medical Distribution industry, placing it in the top 80.6%.
Is Vital KSK Holdings' 9-Day RSI too high?
Vital KSK Holdings' current 9-Day RSI is 59.37. The Medical Distribution industry median 9-Day RSI is 51.54. Vital KSK Holdings' value of 59.37 is 15.2% above this industry median. Based on the distribution chart, Vital KSK Holdings ranks #100 out of 124 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Vital KSK Holdings has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' 9-Day RSI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #100 out of 124 companies for 9-Day RSI. This places Vital KSK Holdings in the lower half of its industry. The industry median 9-Day RSI is 51.54. Vital KSK Holdings' value of 59.37 is 15.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Distribution company?
The median 9-Day RSI among Medical Distribution companies is 51.54, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current 9-Day RSI of 59.37 is 15.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median 9-Day RSI is 51.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current 9-Day RSI is 59.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Vital KSK Holdings (FRA:4GX) has a current 9-Day RSI of 59.37. The stock's GF Value™ is €7.05, compared to a current price of €8.30 — trading 17.7% above its estimated fair value. The current 9-Day RSI is 59.37 and 15.2% above the Medical Distribution industry median of 51.54. Vital KSK Holdings' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Vital KSK Holdings (FRA:4GX), the current 9-Day RSI is 59.37 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (FRA:4GX) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of €8.30 is trading 17.7% above its estimated GF Value™ of €7.05.
Key valuation signals for FRA:4GX:
9-Day RSI: 59.37
GF Value™: €7.05 vs. price of €8.30 (17.7% above fair value)
Industry Position: 15.2% above the Medical Distribution median (#100 of 124)
No single metric tells the full story. See the FRA:4GX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
70GF Score
Get the complete analysis for FRA:4GX
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4GX has been successfully added to your 